SYNOPSYS, INC. |
|
| ||||||
Unaudited Consolidated Balance Sheets (1) |
|
| ||||||
(in thousands, except par value amounts) |
|
| ||||||
|
|
| ||||||
|
|
|
| October 31,
|
| October 31,
|
|
|
ASSETS: |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
| $ 1,417,608 |
| $ 1,432,840 |
|
|
Short-term investments |
|
|
| 147,913 |
| 147,949 |
|
|
Total cash, cash equivalents & short-term investments |
|
|
| $ 1,565,521 |
| $ 1,580,789 |
|
|
Accounts receivable, net |
|
|
| 796,091 |
| 568,501 |
|
|
Inventories |
|
|
| 211,927 |
| 229,023 |
|
|
Prepaid and other current assets |
|
|
| 439,130 |
| 430,028 |
|
|
Total current assets |
|
|
| 3,012,669 |
| 2,808,341 |
|
|
Property and equipment, net |
|
|
| 483,300 |
| 472,398 |
|
|
Operating lease right-of-use assets, net |
|
|
| 559,090 |
| 493,251 |
|
|
Goodwill |
|
|
| 3,842,234 |
| 3,575,785 |
|
|
Intangible assets, net |
|
|
| 386,446 |
| 279,132 |
|
|
Deferred income taxes |
|
|
| 670,653 |
| 612,655 |
|
|
Other long-term assets |
|
|
| 463,695 |
| 510,698 |
|
|
Total assets |
|
|
| $ 9,418,087 |
| $ 8,752,260 |
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES, REDEEMABLE NON-CONTROLLING
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities |
|
|
| $ 809,403 |
| $ 741,191 |
|
|
Operating lease liabilities |
|
|
| 54,274 |
| 79,678 |
|
|
Deferred revenue |
|
|
| 1,910,822 |
| 1,517,623 |
|
|
Short-term debt |
|
|
| - |
| 74,992 |
|
|
Total current liabilities |
|
|
| 2,774,499 |
| 2,413,484 |
|
|
Long-term operating lease liabilities |
|
|
| 581,273 |
| 487,003 |
|
|
Long-term deferred revenue |
|
|
| 154,472 |
| 136,303 |
|
|
Long-term debt |
|
|
| 20,824 |
| 25,094 |
|
|
Other long-term liabilities |
|
|
| 327,829 |
| 391,433 |
|
|
Total liabilities |
|
|
| 3,858,897 |
| 3,453,317 |
|
|
Redeemable non-controlling interest |
|
|
| 38,664 |
| - |
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
|
Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding |
| - |
| - |
|
| ||
Common stock, $0.01 par value: 400,000 shares authorized; 152,375 and
|
|
| 1,524 |
| 1,531 |
|
| |
Capital in excess of par value |
|
|
| 1,487,126 |
| 1,576,363 |
|
|
Retained earnings |
|
|
| 5,534,307 |
| 4,549,713 |
|
|
Treasury stock, at cost: 4,886 and 4,198 shares, respectively |
|
| (1,272,955) |
| (782,866) |
|
| |
Accumulated other comprehensive income (loss) |
|
|
| (234,277) |
| (49,604) |
|
|
Total Synopsys stockholders' equity |
|
|
| 5,515,725 |
| 5,295,137 |
|
|
Non-controlling interest |
|
|
| 4,801 |
| 3,806 |
|
|
Total stockholders' equity |
|
|
| 5,520,526 |
| 5,298,943 |
|
|
Total liabilities, redeemable non-controlling interest and
|
|
|
| $ 9,418,087 |
| $ 8,752,260 |
|
|
|
|
|
|
|
|
|
|
|
(1) Synopsys' fiscal year 2022 and 2021 ended on October 29, 2022 and October 30, 2021, respectively. For presentation
|
|
| ||||||
|
|